Burning Rock Biotech Limited (NASDAQ:BNR) Sees Large Decline in Short Interest

Burning Rock Biotech Limited (NASDAQ:BNR) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 72,300 shares, a decrease of 10.3% from the November 15th total of 80,600 shares. Based on an average daily trading volume, of 33,600 shares, the days-to-cover ratio is presently 2.2 days. Currently, 0.9% of the company’s stock are short sold.

Burning Rock Biotech Price Performance

Shares of BNR traded down $0.21 during mid-day trading on Friday, reaching $6.73. The company’s stock had a trading volume of 5,862 shares, compared to its average volume of 13,929. Burning Rock Biotech has a 12-month low of $2.62 and a 12-month high of $9.99. The stock has a market cap of $68.94 million, a PE ratio of -2.24 and a beta of 0.60. The company’s 50 day moving average is $4.28 and its 200 day moving average is $5.35.

Hedge Funds Weigh In On Burning Rock Biotech

A hedge fund recently bought a new stake in Burning Rock Biotech stock. SkyView Investment Advisors LLC purchased a new stake in Burning Rock Biotech Limited (NASDAQ:BNR) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 10,000 shares of the company’s stock, valued at approximately $64,000. SkyView Investment Advisors LLC owned about 0.10% of Burning Rock Biotech at the end of the most recent reporting period. 30.03% of the stock is owned by institutional investors and hedge funds.

Burning Rock Biotech Company Profile

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples.